Roth Capital Positive on 22nd Century Group (XXII): 'position to potentially expand even quicker than the targeted' Jan 18, 2023 11:45AM
Roth Capital Keeps $5 Price Target on 22nd Century Group (XXII): 'Full Steam Ahead with FDA Menthol Ban' Jan 18, 2023 08:03AM
22nd Century Group (Nasdaq: XXII) Strengthens Balance Sheet to Accelerate the Expansion of VLN Launch Jul 21, 2022 10:00AM
22nd Century Group (Nasdaq: XXII) Strengthens Balance Sheet to Accelerate the Expansion of VLN Launch Jul 21, 2022 10:00AM
22nd Century Group (XXII) Prices 17M Share Offering at $2.05/sh Jul 21, 2022 09:00AM


Jul 21, 2022 09:00AM 22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
Jul 21, 2022 09:00AM 22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
Jun 22, 2022 08:23AM Roth Capital on Nicotine in US and Benefits to 22nd Century Group (XXII), 'only FDA-approved minimum nicotine content cigarettes on the market'
May 27, 2022 09:25AM 22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings
May 6, 2022 07:48AM 22nd Century Group (XXII) Beats on Initial Sales of VLN Cigs - Roth Capital
May 5, 2022 06:07AM 22nd Century Group (XXII) Reports Q1 Revenue of $9M, EPS of ($0.05), Provides Business Highlights
May 5, 2022 06:00AM 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022
Mar 9, 2022 09:30AM 22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
Nov 11, 2021 09:20AM 22nd Century to Participate in Cowen and Roth Capital Investor Conferences in November 2021